Tesalin® – Ze 339
For the treatment of intermittent (seasonal) allergic rhinitis and related symptoms of the eyes, nose and throat
17.8 - 40 mg CO2 extract (Ze 339) from the leaves of Petasites hybridus, standardized to 8 mg petasins
Drug-extract ratio (DER): 50-100:1
Patented sub-critical CO2 extraction
2-3 x 1 film-coated tablets per day.
Clinical Evidence & Mode of action
The information contained in this section is intended for healthcare professionals only.
Please click the button below to confirm that you are a healthcare professional.
Ze 339 – The Difference
New Herbal Entity – Ze 339 is the first Petasites hybridus leaf extract for the treatment of allergic rhinitis, with no similar product worldwide
Dual action – Alleviates broad range of allergic rhinitis complaints including allergic (rhinorrhea, itching etc.) and inflammatory symptoms (nasal congestion) by inhibiting synthesis of leukotrienes and release of various inflammatory mediators
Highly effective - Proven equal efficacy in head-to-head trials with antihistamines
Excellent safety & tolerability – Low incidence of adverse effects and no sedative effect